InvestWiser

Stille AB

STILNasdaq StockholmHealthcareMarket value 2.3 bn SEK
254.50SEK −1.7%
last day · Price as of 18 November 2026

The answer first

Does Stille beat the market?

Yes, Stille has beaten the market over the last year.

Stille+43.8%Stockholm (OMXSGI)+17.6%
  • The ranking · Quality, value and trend combined

    Better than 88% of Nordic stocks

    • Quality96
    • Value32
    • Trend83

    No. 13 of 195 in healthcare

  • Expectations in the price

    High expectations

    For the share to return about 9% a year from today's price, the cash Stille keeps must grow about 14% a year for 10 years.

Max for seven days

Follow Stille with Aurora

Aurora lets you know at the next report. No card.

Both with dividends. Figures as of 18 November 2026. General analysis, not personal advice.

Follow your thesis

Follow your thesis on Stille

From today, at a price of 254.50 SEK. Write why you follow Stille, and choose what Aurora should tell you about.

What should Aurora follow?

Free, no card. The mission is ready when your account is.

Aurora tells you that something happened. What you do is your choice.

Ask Aurora about Stille

Your first answer is free, no account needed.

Do you own Stille, or are you thinking about it?

See it next to the rest of your portfolio, or build your first one with Stille and a few more. Free, no card.

Past year against the exchange and Super Stock
Stille+43.8%Stockholm (OMXSGI)+17.6%Super Stock+44.6%
17 November 202518 November 2026
All start at 0 % a year ago, with dividends. Super Stock is our model portfolio: the 20 highest-ranked Nordic stocks on quality, value and trend.

In short

  • Stille has risen 43.8% over the past year, including dividends.
  • Overall, Stille ranks better than 88% of Nordic stocks on quality, value and trend.
  • The largest fall over the past three years was 46.1%. The price is 7.8% below its peak now.

What do analysts think of Stille?

Quality, value and trend

Quality is about the company, value about the price you pay, and trend about the share price. Each pillar shows the numbers it is built on.

88

Quality, value and trend together. Better than 88% of Nordic stocks.

No. 13 of 195 in healthcare

Quality96
The company · Fundamentals: the accounts

High A solid company: it earns well on its money and has healthy finances.

No. 15 of 196 in healthcareTypical in healthcare: 64Typical in the Nordics: 50

  • Debt to equityBorrowings divided by equity0.08
  • Asset turnoverSales divided by everything the company owns0.61
  • Return on equityProfit divided by equity+11.9%
  • Cash conversionOperating cash flow divided by profit0.91

The ranking is built on equity ratio, ROA and how steadily profit grows.

Value32
The price · Valuation: the multiples

Low High price: buyers pay a lot today, often because they expect growth.

No. 72 of 197 in healthcareTypical in healthcare: 20Typical in the Nordics: 50

  • P/BPrice divided by equity2.8
  • P/SPrice divided by sales3.2
  • P/EPrice divided by earnings23.4
  • P/CFPrice divided by operating cash flow25.7

The ranking is built on P/E, P/B and P/S.

Trend83
The share price · Technical: the price trend

High Tailwind in the share price: it has risen more than most over the last year.

No. 38 of 198 in healthcareTypical in healthcare: 34Typical in the Nordics: 50

  • 3 months+9.7%
  • 6 months−1.0%
  • 9 months+35.0%
  • 12 months+43.8%

The ranking is built on 3, 6 and 12–1 months.

Return and risk

1 month
−0.2%
3 years, per year
+33.9%
5 years, per year
+12.3%
10 years, per year
+20.5%
Largest fall, 3 years
−46.1%
From a peak to the bottom
From the peak now
−7.8%
How far the price is from the peak
Volatility, 1 year
44.4%
How much the price swings over a year
Beta, 1 year
−0.02
How much the price moves when the market moves

Return with dividends reinvested.

The funds that own Stille

3 funds we follow own Stille. The share is how much of the fund the stock makes up.

  • Norway1
  • Sweden2

From the funds' latest known holdings.

About Stille

Stille AB is a company in healthcare, listed on Nasdaq Stockholm. The share trades in SEK. It has around 240 employees.

Stille AB (publ) develops, manufactures, and distributes medtech products in Sweden, Germany, the United Kingdom, Switzerland, North America, the United States, and internationally. It operates through the Surgical Instruments and Surgical Tables segments. The Surgical Instruments segment offers surgical scissors, including SuperCut, eye, blepharoplasty, operating, vascular, tenotomy, and face-lift scissors; colon, gall duct, multi-purpose, tangential occlusion, peripheral vascular, and anastomosis clamps; skin and nerve hooks, retractors, rib spreaders, self-retaining and trachea retractors, and nasal specula; and dressing, diathermy, knot-holding, tissue, iris, dura, and vascular forceps u…

See the full analysis of Stille.

The accounts, dividends, 40 years of charts and the comparison with other stocks are in the app.

Free forever · No card

Other healthcare stocks on Nasdaq Stockholm

Explore the stock market